NASDAQ: APDNApplied Dna Sciences Inc Stock
$4.97+0.10 (+2.05%)
Updated Aug 9, 2022
APDN Price
$4.97
Fair Value Price
$5.92
Market Cap
$40.92M
52 Week Low
$0.62
52 Week High
$7.35
P/E
-2.56x
P/B
5.35x
P/S
1.15x
PEG
N/A
Dividend Yield
N/A
Revenue
$15.05M
Earnings
-$14.44M
Gross Margin
32.1%
Operating Margin
-96%
Profit Margin
-96.7%
Debt to Equity
0.82
Operating Cash Flow
-$10M
Beta
0.19
Next Earnings
Aug 10, 2022
Ex-Dividend
N/A
Next Dividend
N/A
APDN Overview
Zen Score
–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how APDN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
APDN ($4.97) is undervalued by 16.01% relative to our estimate of its Fair Value price of $5.92 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
APDN ($4.97) is not significantly undervalued (16.01%) relative to our estimate of its Fair Value price of $5.92 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
APDN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more APDN due diligence checks available for Premium users.
APDN News
Valuation
APDN fair value
Fair Value of APDN stock based on Discounted Cash Flow (DCF)
Price
$4.97
Fair Value
$5.92
Undervalued by
16.01%
APDN ($4.97) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
APDN ($4.97) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
APDN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
APDN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.56x
Industry
-24.92x
Market
32.55x
APDN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.35x
Industry
4.19x
APDN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
APDN's financial health
Profit margin
Revenue
$6.1M
Net Income
-$1.8M
Profit Margin
-30.4%
APDN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
APDN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$13.9M
Liabilities
$6.2M
Debt to equity
0.82
APDN's short-term assets ($11.16M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
APDN's short-term assets ($11.16M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
APDN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
APDN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$261.9k
Investing
-$65.5k
Financing
$4.1M
APDN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
APDN vs Security & Protection Service Stocks
Applied Dna Sciences Stock FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.